7267de96__Companies___Flagship_Ventures__Status
[Description] Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. [Initial Date] 2006 [4] View Profile [Status] 
Public
A c q u i r e d
P u b l i c
P r i v a t e
All Companies | Flagship Ventures
Status